JPH10279549A - Quinone derivative - Google Patents
Quinone derivativeInfo
- Publication number
- JPH10279549A JPH10279549A JP9096699A JP9669997A JPH10279549A JP H10279549 A JPH10279549 A JP H10279549A JP 9096699 A JP9096699 A JP 9096699A JP 9669997 A JP9669997 A JP 9669997A JP H10279549 A JPH10279549 A JP H10279549A
- Authority
- JP
- Japan
- Prior art keywords
- chloroform
- group
- compound
- naphthoquinone
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004059 quinone derivatives Chemical class 0.000 title claims description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 54
- 239000000178 monomer Substances 0.000 claims abstract description 38
- 229930192627 Naphthoquinone Natural products 0.000 claims abstract description 24
- 150000002791 naphthoquinones Chemical class 0.000 claims abstract description 23
- 125000001841 imino group Chemical group [H]N=* 0.000 claims abstract description 18
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 claims description 25
- 150000004056 anthraquinones Chemical class 0.000 claims description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 103
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 abstract description 33
- SLKDGVPOSSLUAI-PGUFJCEWSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCN)OC(=O)CCCCCCCCCCCCCCC SLKDGVPOSSLUAI-PGUFJCEWSA-N 0.000 abstract description 21
- 239000002904 solvent Substances 0.000 abstract description 20
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 abstract description 18
- 239000000203 mixture Substances 0.000 abstract description 18
- -1 succinimide compound Chemical class 0.000 abstract description 16
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 abstract description 7
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 abstract description 7
- 229910052736 halogen Inorganic materials 0.000 abstract description 7
- 150000002367 halogens Chemical class 0.000 abstract description 7
- 229960002317 succinimide Drugs 0.000 abstract description 7
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 abstract description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 abstract description 6
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract description 5
- 150000003904 phospholipids Chemical group 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract description 2
- 238000000338 in vitro Methods 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 63
- 238000006243 chemical reaction Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000027756 respiratory electron transport chain Effects 0.000 description 10
- 239000012467 final product Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 125000002947 alkylene group Chemical group 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- ARQRPTNYUOLOGH-UHFFFAOYSA-N chcl3 chloroform Chemical compound ClC(Cl)Cl.ClC(Cl)Cl ARQRPTNYUOLOGH-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229940076442 9,10-anthraquinone Drugs 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 238000002484 cyclic voltammetry Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 150000002632 lipids Chemical group 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- PBLZLIFKVPJDCO-UHFFFAOYSA-N 12-aminododecanoic acid Chemical compound NCCCCCCCCCCCC(O)=O PBLZLIFKVPJDCO-UHFFFAOYSA-N 0.000 description 2
- SVPKNMBRVBMTLB-UHFFFAOYSA-N 2,3-dichloronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(Cl)=C(Cl)C(=O)C2=C1 SVPKNMBRVBMTLB-UHFFFAOYSA-N 0.000 description 2
- ABSTXSZPGHDTAF-UHFFFAOYSA-N 4-amino-pentanoic acid Chemical compound CC(N)CCC(O)=O ABSTXSZPGHDTAF-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- RZVHIXYEVGDQDX-UHFFFAOYSA-N 9,10-anthraquinone Chemical group C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 2
- ASDLSKCKYGVMAI-UHFFFAOYSA-N 9,10-dioxoanthracene-2-carboxylic acid Chemical compound C1=CC=C2C(=O)C3=CC(C(=O)O)=CC=C3C(=O)C2=C1 ASDLSKCKYGVMAI-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910021397 glassy carbon Inorganic materials 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- KETQAJRQOHHATG-UHFFFAOYSA-N 1,2-naphthoquinone Chemical compound C1=CC=C2C(=O)C(=O)C=CC2=C1 KETQAJRQOHHATG-UHFFFAOYSA-N 0.000 description 1
- 229940105324 1,2-naphthoquinone Drugs 0.000 description 1
- KPYPNTLKDIYIKB-UHFFFAOYSA-N 2,3-dichloroanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=C(Cl)C(Cl)=C2 KPYPNTLKDIYIKB-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical group N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明が属する技術分野】本発明は、新規のキノン誘導
体に関する。TECHNICAL FIELD The present invention relates to a novel quinone derivative.
【0002】[0002]
【従来の技術】有機化合物には陰陽各イオンの伝達機能
やそれに関連したエネルギー変換機能を有するものが知
られている。例えば、ポルフィン骨格に種々の基が置換
した天然及び人為的に合成された誘導体には、電子また
は陰イオン伝達機能やエネルギ−変換機能を備えたもの
が比較的多く存在することが知られている。2. Description of the Related Art As organic compounds, those having a function of transferring each ion of anion and cation and an energy conversion function related thereto are known. For example, it is known that a relatively large number of natural and artificially synthesized derivatives having a porphine skeleton substituted with various groups have an electron or anion transfer function and an energy conversion function. .
【0003】一方、ミトコンドリア内膜や光合成膜を構
成する色素群として知られているキノン誘導体も、生体
内に於いて電子伝達媒体として作用し、例えば光エネル
ギーを化学エネルギーに変換するようなエネルギー変換
機能を有する可能性が指摘されている。しかし、キノン
誘導体はエネルギー移動のアクセプター成分としての解
明がこれまで主として行われてきたものの、その電子伝
達挙動の詳細については殆ど解明されていない。また該
電子伝達挙動を有するキノン誘導体も、例えば蛋白質複
合体間で電子伝達を行う疎水性補酵素であるユビキノン
(コエンザイムQ)など僅かな生体内化合物が知られて
いる程度である。[0003] On the other hand, quinone derivatives known as a group of dyes constituting a mitochondrial inner membrane or a photosynthetic membrane also act as an electron transfer medium in a living body, for example, energy conversion such as converting light energy into chemical energy. It is pointed out that it may have a function. However, although quinone derivatives have been mainly elucidated as an acceptor component for energy transfer, the details of the electron transfer behavior have not been elucidated. Also, as for the quinone derivative having the electron transfer behavior, only a few in vivo compounds such as ubiquinone (coenzyme Q), which is a hydrophobic coenzyme that transfers electrons between protein complexes, are known.
【0004】[0004]
【発明が解決すべき課題】本発明は、非生体内に於いて
も電子伝達機能を有する新規のキノン誘導体、特にナフ
トキノン単量体化合物およびアントラキノン単量体化合
物を提供するものである。SUMMARY OF THE INVENTION The present invention provides a novel quinone derivative having an electron transfer function even in a non-living body, particularly a naphthoquinone monomer compound and an anthraquinone monomer compound.
【0005】[0005]
【課題を解決するための手段】前記課題に対し、本発明
者らは鋭意検討した結果、ナフトキノンやアントラキノ
ンの2、3位の何れか1つの水素原子を、適宜長さのア
ルキレン鎖を付加させたイミノ基か、同様に適宜長さの
アルキレン鎖を付加させた−CONH−で表される基で
置換したもので構成される基や、更にこのようなアルキ
レン鎖を付加させたイミノ基か−CONH−で表される
基が2、3位の何れかに置換したナフトキノンやアント
ラキノンであって、2、3位のうち該基が置換していな
い方の水素原子をハロゲン原子で置換したもので構成さ
れる基からなるナフトキノン単量体化合物やアントラキ
ノン単量体化合物は、何れも新規のキノン誘導体である
ことを見出し、しかもこのような誘導体は電子伝達機能
を有するものであることを見出した。Means for Solving the Problems In view of the above problems, the present inventors have conducted intensive studies and found that one of the hydrogen atoms at the 2- and 3-positions of naphthoquinone and anthraquinone was added to an alkylene chain of an appropriate length. Or an imino group similarly substituted with a group represented by -CONH- to which an alkylene chain having an appropriate length has been added, or an imino group further having such an alkylene chain added thereto- A group represented by CONH- is naphthoquinone or anthraquinone substituted at any of the 2- and 3-positions, wherein a hydrogen atom which is not substituted at the 2- or 3-position is substituted with a halogen atom; Both naphthoquinone monomer compounds and anthraquinone monomer compounds composed of the constituent groups have been found to be novel quinone derivatives, and such derivatives have an electron transfer function. It was found that.
【0006】即ち、本発明のキノン誘導体は、一般式
(3)That is, the quinone derivative of the present invention has the general formula (3)
【0007】[0007]
【化3】 Embedded image
【0008】[式(3)中、R1はイミノ基または−C
ONH−で表される基、R2は水素またはハロゲン原
子、nは2〜20の整数を表す。]で示される基からな
るナフトキノン単量体化合物を特徴とするものである。[In the formula (3), R 1 represents an imino group or -C
Groups represented by ONH-, R 2 represents a hydrogen or halogen atom, n represents an integer of 2 to 20. And a naphthoquinone monomer compound comprising a group represented by the formula:
【0009】また本発明のキノン誘導体は、一般式
(4)The quinone derivative of the present invention has the general formula (4)
【0010】[0010]
【化4】 Embedded image
【0011】[式(4)中、R1はイミノ基または−C
ONH−で表される基、R2は水素またはハロゲン原
子、nは2〜20の整数を表す。]で示される基からな
るアントラキノン単量体化合物を特徴とするものであ
る。[In the formula (4), R 1 represents an imino group or -C
Groups represented by ONH-, R 2 represents a hydrogen or halogen atom, n represents an integer of 2 to 20. ] Anthraquinone monomer compound comprising a group represented by the formula:
【0012】[0012]
【発明の実施の形態】本発明に於けるキノン誘導体は、
前記一般式(3)で表される基からなるナフトキノン単
量体化合物であって、該基は、1,4−ナフトキノンの
2、3位の水素の何れかをイミノ基又は−CONH−で
表される基(R1)で置換し、更に該イミノ基又は−C
ONH−で表される基に適意の長さのアルキレン鎖が結
合、即ち一般式(3)中でnが2〜20の整数の何れか
となるアルキレン基が結合したものであって、ナフトキ
ノンの2、3位のイミノ基又は−CONH−で表される
基が置換していない方の水素は水素のままか又はハロゲ
ン原子で置換(R2)したものである。このような基か
らなるナフトキノンの単量体化合物としては、例えば該
基に−COOHが結合した化合物などを挙げることがで
きるが、特に該基に脂質が結合したものや、金属に結合
したものが好ましい。BEST MODE FOR CARRYING OUT THE INVENTION The quinone derivative in the present invention comprises:
A naphthoquinone monomer compound comprising a group represented by the general formula (3), wherein any one of hydrogens at positions 2 and 3 of 1,4-naphthoquinone is represented by an imino group or -CONH-. is the is substituted with a group (R 1), further said imino group or -C
An alkylene chain of an appropriate length is bonded to a group represented by ONH-, that is, an alkylene group in which n is any integer from 2 to 20 in the general formula (3), and , hydrogen Write a group represented by the 3-position of the imino group or -CONH- not substituted are those substituted with either left or halogen atom of the hydrogen (R 2). Examples of the naphthoquinone monomer compound having such a group include a compound in which -COOH is bonded to the group, and in particular, a compound in which lipid is bonded to the group and a compound in which metal is bonded to the group. preferable.
【0013】また本発明に於けるキノン誘導体は、前記
一般式(4)で表される基からなるアントラキノン単量
体化合物であって、該基は、9,10−アントラキノン
の2、3位の水素の何れかをイミノ基又は−CONH−
で表される基(R1)で置換し、更に該イミノ基又は−
CONH−で表される基に適意の長さのアルキレン鎖が
結合、即ち一般式(4)中でnが2〜20の整数の何れ
かとなるアルキレン基が結合したものであって、アント
ラキノンの2、3位のイミノ基又は−CONH−で表さ
れる基が置換していない方の水素は水素のままか又はハ
ロゲン原子で置換したもの(R2)である。このような
基からなるアントラキノンの単量体化合物としては、例
えば該基に−COOHが結合した化合物などを挙げるこ
とができるが、望ましくは該基に脂質が結合したもの
や、金属が結合したものが好ましい。The quinone derivative according to the present invention is an anthraquinone monomer compound comprising a group represented by the general formula (4), wherein the group is a 2,3-position of 9,10-anthraquinone. Any of hydrogen is replaced with an imino group or -CONH-
Substituted with a group represented by (R 1), further said imino group or -
An alkylene chain having an appropriate length bonded to the group represented by CONH-, that is, an alkylene group in which n is any integer from 2 to 20 in the general formula (4), and the anthraquinone 2 The hydrogen not substituted by the imino group at the 3-position or the group represented by -CONH- is hydrogen (R 2 ), which is still hydrogen or substituted with a halogen atom. Examples of the anthraquinone monomer compound having such a group include a compound in which -COOH is bonded to the group, and a compound in which lipid is bonded to the group or a metal in which metal is bonded is preferable. Is preferred.
【0014】前記何れのキノン誘導体も、市販薬品など
の公知化合物を用いて、既知の一般的な合成プロセスに
より得ることができる。即ち、ナフトキノン単量体化合
物として、例えば、前記一般式(3)で示される基がn
=2でR1がイミノ基であって、該基と燐脂質が結合し
てなる単量体化合物の場合、1,4−ナフトキノン、又
はこれをハロゲン化した2,3−ジハロゲン−1,4−
ナフトキノン(ハロゲンとしては、塩素、フッ素、臭
素、沃素の何れか)をクロロホルムに溶解した3−アミ
ノプロピオン酸を添加、トリエチルアミンを滴下後還流
し、溶媒留去後したものをクロロホルムに溶解させ、こ
れにN−ヒドロキシスクシンイミドとN,N’−ジシク
ロヘキシルカルボジイミドを加え、撹拌濾過後溶媒留去
する。得られたスクシンイミド化合物をクロロホルムに
溶解し、ジパルミトイルホスファチジルエタノールアミ
ン(DPPE)のクロロホルム溶液を加え、トリメチル
アミンを滴下し、溶媒抽出することにより、(C10H4
O2)H(NH)−(CH2)2−で表される基を有する
ナフトキノン単量体化合物:(C10H4O2)H(NH)
−(CH2)2−DPPE、又は(C10H4O2)X(N
H)−(CH2)2−で表される基を[但し、Xはハロゲ
ン]有するナフトキノン単量体化合物:(C10H4O2)
X(NH)−(CH2)2−DPPEを得ることができ
る。溶媒抽出後の生成物(溶質)が混合物の場合は、一
般的な分離操作、例えばカラムクロマトグラフィー等に
より容易に分離することができる。Each of the above quinone derivatives can be obtained by a known general synthesis process using a known compound such as a commercially available drug. That is, as the naphthoquinone monomer compound, for example, a group represented by the general formula (3) is represented by n
= 2, R 1 is an imino group and the monomer compound is a phospholipid-bonded 1,2-naphthoquinone or 2,3-dihalogen-1,4 obtained by halogenating the compound. −
3-Aminopropionic acid in which naphthoquinone (halogen is chlorine, fluorine, bromine, or iodine) dissolved in chloroform is added, triethylamine is added dropwise, and the mixture is refluxed. N-Hydroxysuccinimide and N, N'-dicyclohexylcarbodiimide are added to the mixture, and the mixture is filtered with stirring, and the solvent is distilled off. The obtained succinimide compound was dissolved in chloroform, a chloroform solution of dipalmitoylphosphatidylethanolamine (DPPE) was added, trimethylamine was added dropwise, and the mixture was extracted with (C 10 H 4).
Naphthoquinone monomer compound having a group represented by O 2 ) H (NH)-(CH 2 ) 2- : (C 10 H 4 O 2 ) H (NH)
-(CH 2 ) 2 -DPPE or (C 10 H 4 O 2 ) X (N
H) -Naphthoquinone monomer compound having a group represented by-(CH 2 ) 2- where X is a halogen: (C 10 H 4 O 2 )
X (NH) - (CH 2 ) can be obtained 2 DPPE. When the product (solute) after solvent extraction is a mixture, it can be easily separated by a general separation operation, for example, column chromatography or the like.
【0015】また、ナフトキノン単量体化合物として、
例えば前記一般式(3)で示される基が、nが3以上2
0以下の整数でR1がイミノ基であって、該基と燐脂質
(DPPE)が結合してなる単量体化合物の場合、(n
+1)−アミノカルボン酸を、1,4−ナフトキノン又
は2,3−ジハロゲン−1,4−ナフトキノンに加えた
ものから、前記と同様の合成手法により、(C10H
4O2)H(NH)−(CH2)n−で表される基[但し、
n=3〜20の整数]を有するナフトキノン単量体化合
物:(C10H4O2)H(NH)−(CH2)n−DPP
E、又は(C10H4O2)X(NH)−(CH2)n−で表
される基[但し、Xはハロゲン、n=3〜20の整数]
を有するナフトキノン単量体化合物:(C10H4O2)X
(NH)−(CH2)n−DPPEを得ることができる。Further, as a naphthoquinone monomer compound,
For example, when the group represented by the general formula (3) is such that n is 3 or more and 2
In the case of a monomer compound in which R 1 is an imino group with an integer of 0 or less and the group is bonded to a phospholipid (DPPE), (n
+1) -Aminocarboxylic acid was added to 1,4-naphthoquinone or 2,3-dihalogen-1,4-naphthoquinone by the same synthesis method as described above to obtain (C 10 H).
4 O 2 ) H (NH)-(CH 2 ) n-
naphthoquinone monomeric compounds having an integer of n = 3~20: (C 10 H 4 O 2) H (NH) - (CH 2) n -DPP
E, or (C 10 H 4 O 2) X (NH) - (CH 2) n - group represented by [where, X is a halogen, n = 3 to 20 integer]
Naphthoquinone monomer compound having: (C 10 H 4 O 2 ) X
(NH) - (CH 2) n -DPPE can be obtained.
【0016】また、アントラキノン単量体化合物とし
て、例えば前記一般式(4)で示される基が、nが2で
R1がイミノ基であって、該基と燐脂質が結合してなる
単量体化合物の場合、9,10−アントラキノン、又は
2,3−ジハロゲン−9,10−アントラキノン(ハロ
ゲンとしては、塩素、フッ素、臭素、沃素の何れか)を
クロロホルムに溶解し、エタノールに溶解した3−アミ
ノプロピオン酸を添加、トリエチルアミンを滴下後還流
し、溶媒除去したものをクロロホルムに溶解させ、N−
ヒドロキシスクシンイミドとN,N’−ジシクロヘキシ
ルカルボジイミドを加え撹拌濾過後溶媒留去する。得ら
れたスクシンイミド化合物をクロロホルムに溶解し、ジ
パルミトイルホスファチジルエタノールアミン(DPP
E)のクロロホルム溶液を加え、トリメチルアミンを滴
下還流することにより、(C14H6O2)H(NH)−
(CH2)2−で表される基を有するアントラキノン単量
体化合物:(C14H6O2)H(NH)−(CH2)2−D
PPE、又は(C14H6O2)X(NH)−(CH2)2−
で表される基[但し、Xはハロゲン]を有するアントラ
キノン単量体化合物:(C14H6O2)X(NH)−(C
H2)2−DPPEを得ることができる。Further, as the anthraquinone monomer compound, for example, a group represented by the general formula (4) wherein n is 2 and R 1 is an imino group and the group is bonded to a phospholipid, In the case of the isomer compound, 9,10-anthraquinone or 2,3-dihalogen-9,10-anthraquinone (halogen is chlorine, fluorine, bromine or iodine) is dissolved in chloroform and dissolved in ethanol. -Aminopropionic acid was added, triethylamine was added dropwise, and the mixture was refluxed. The solvent was removed and the residue was dissolved in chloroform.
Hydroxysuccinimide and N, N'-dicyclohexylcarbodiimide are added, the mixture is stirred and filtered, and the solvent is distilled off. The obtained succinimide compound is dissolved in chloroform, and dipalmitoylphosphatidylethanolamine (DPP
Chloroform was added and E), by dropping reflux trimethylamine, (C 14 H 6 O 2 ) H (NH) -
(CH 2) 2 - anthraquinone monomer compound having a group represented by: (C 14 H 6 O 2 ) H (NH) - (CH 2) 2 -D
PPE, or (C 14 H 6 O 2) X (NH) - (CH 2) 2 -
A group represented by [where, X is halogen anthraquinone monomer compound having: (C 14 H 6 O 2 ) X (NH) - (C
H 2 ) 2 -DPPE can be obtained.
【0017】また、アントラキノン単量体化合物とし
て、例えば前記一般式(4)で示される基が、nが3以
上20以下の整数でR1がイミノ基であって、該基と燐
脂質(DPPE)が結合してなる誘導体の場合、任意の
長さの(n+1)−アミノカルボン酸に9,10−アン
トラトキノン又は2,3−ジハロゲン−9,10−アン
トラトキノンに加えたものから、前記と同様の合成手法
により、(C14H6O2)H(NH)−(CH2)n−で表
される基[但し、n=3〜20の整数]を有するアント
ラキノン単量体化合物:(C14H6O2)H(NH)−
(CH2)n−DPPE、又は(C14H6O2)X(NH)
−(CH2)n−で表される基[但し、Xはハロゲン、n
=3〜20の整数]を有するアントラキノン単量体化合
物:(C14H6O2)X(NH)−(CH2)n−DPPE
を得ることができる。Further, as the anthraquinone monomer compound, for example, the group represented by the above general formula (4) is such that n is an integer of 3 or more and 20 or less and R 1 is an imino group, and the group is combined with a phospholipid (DPPE ) Is a derivative obtained by adding (10) -anthraquinone or 2,3-dihalogen-9,10-anthraquinone to (n + 1) -aminocarboxylic acid of any length, the synthesis method similar to the above, (C 14 H 6 O 2 ) H (NH) - (CH 2) n - group represented by [where integer n = 3 to 20] anthraquinone monomeric compounds having a : (C 14 H 6 O 2 ) H (NH) -
(CH 2) n -DPPE, or (C 14 H 6 O 2) X (NH)
-(CH 2 ) n-wherein X is a halogen, n
= Anthraquinone monomeric compounds having 3 to 20 integer]: (C 14 H 6 O 2) X (NH) - (CH 2) n -DPPE
Can be obtained.
【0018】[0018]
【実施例】以下、本発明を実施例により詳細に説明す
る。 [実施例1] 300mlの三口フラスコ中に2,3−
ジクロロ−1,4−ナフトキノン519.3mg(2.
29mmol)を入れ、クロロホルム20mlに溶解さ
せた。これに、エタノール10体積部に対し、水1体積
部を混合した溶液33mlに溶解させた3−アミノプロ
ピオン酸136mg(1.52mmol)を徐々に添加
した後、トリエチルアミンを滴下し、60℃で90分反
応させた。反応液を濾過し、溶媒留去したものをクロロ
ホルム100mlに再度溶解させ、蒸留水で水洗を行っ
た。次いで、シリカゲルクロマトグラフィー(溶離液:
クロロホルム〜クロロホルム/メタノール=40/1
(クロロホルムとメタノールが40:1の体積比で混合
した溶液を表す。以下同様の記載方式で表す))により
分離精製した生成物を溶媒留去後、真空乾燥させ、粉末
状のアミノプロピオン酸ナフトキノンを得た。これを1
00ml二口フラスコ中に87mg(0.310mmo
l)入れ、クロロホルム20mlに溶解させた。次い
で、N−ヒドロキシスクシンイミド53.7mg(0.
466mol)とN,N’−ジシクロヘキシルカルボジ
イミド(DCC)96.2mg(0.466mmol)
を加え、0℃で1時間撹拌した後、室温で11時間反応
を行った。これにクロロホルム100mlを加えて濾過
した後、蒸留水で水洗し、有機相を溶媒留去した。得ら
れたアミノカプロン酸ナフトキノンのスクシンイミド化
合物にクロロホルム20mlを加えて溶解し、これにジ
パルミトイルホスファチジルエタノールアミン(DPP
E)172mg(0.249mmol)のクロロホルム
溶液25mlを加え、トリエチルアミンを数滴滴下し室
温で20時間反応させた。反応後、溶媒留去し、シリカ
ゲルカラムトグラフィー(溶離液:クロロホルム〜クロ
ロホルム/メタノール=40/1〜クロロホルム/メタ
ノール=20/1〜クロロホルム/メタノール=9/1
〜クロロホルム/メタノール=4/1)により分離精製
し、溶媒留去、真空乾燥することにより最終生成物を得
た。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail with reference to embodiments. Example 1 In a 300 ml three-necked flask, 2,3-
519.3 mg of dichloro-1,4-naphthoquinone (2.
29 mmol) and dissolved in 20 ml of chloroform. 136 mg (1.52 mmol) of 3-aminopropionic acid dissolved in 33 ml of a solution obtained by mixing 1 part by volume of water with 10 parts by volume of ethanol was gradually added thereto, and triethylamine was added dropwise. Minutes. The reaction solution was filtered, and the solvent was distilled off. The residue was dissolved again in 100 ml of chloroform and washed with distilled water. Then, silica gel chromatography (eluent:
Chloroform-chloroform / methanol = 40/1
(Represents a solution in which chloroform and methanol are mixed at a volume ratio of 40: 1. The product separated and purified by) is distilled off the solvent, dried in vacuo, and powdered naphthoquinone aminopropionate. I got This one
87 mg (0.310 mmo) in a 00 ml two-necked flask
l) and dissolved in 20 ml of chloroform. Then, 53.7 mg of N-hydroxysuccinimide (0.
466 mol) and 96.2 mg (0.466 mmol) of N, N'-dicyclohexylcarbodiimide (DCC)
After stirring at 0 ° C. for 1 hour, the reaction was carried out at room temperature for 11 hours. After adding 100 ml of chloroform thereto and filtering, the mixture was washed with distilled water and the organic phase was evaporated. To the obtained succinimide compound of naphthoquinone aminocaproate was added and dissolved 20 ml of chloroform, and dipalmitoylphosphatidylethanolamine (DPP) was added thereto.
E) 25 ml of a chloroform solution of 172 mg (0.249 mmol) was added, and several drops of triethylamine were added dropwise, and the mixture was reacted at room temperature for 20 hours. After the reaction, the solvent was distilled off and silica gel column chromatography (eluent: chloroform to chloroform / methanol = 40/1 to chloroform / methanol = 20/1 to chloroform / methanol = 9/1).
To chloroform / methanol = 4/1), and the final product was obtained by evaporating the solvent and drying under vacuum.
【0019】最終生成物は、1HNMRスペクトルなど
の公知の分析法で同定し、このうちUV/vis吸収ス
ペクトル(媒体:CHCl3、CH2Cl2/EtOH=
9/1及び0.01MのBis−Tris緩衝液で調整
したリポソーム溶液)の分析では、236、276、4
75nmにそれぞれ吸収が見られたことなどから、最終
生成物は燐脂質(DPPE)に結合した式(5)で表さ
れるナフトキノン単量体化合物:(C6H4O2)Cl
(NH)(CH2)2(DPPE)であることを確認し
た。(収率約73.7%)The final product is identified by a known analytical method such as 1 H NMR spectrum, and the UV / vis absorption spectrum (medium: CHCl 3 , CH 2 Cl 2 / EtOH =
Analysis of liposome solutions prepared with 9/1 and 0.01 M Bis-Tris buffer) indicated 236, 276, 4
Since the absorption was observed at 75 nm, the final product was a naphthoquinone monomer compound represented by the formula (5) bound to phospholipid (DPPE): (C 6 H 4 O 2 ) Cl
It was confirmed to be (NH) (CH 2 ) 2 (DPPE). (Yield about 73.7%)
【0020】[0020]
【化5】 Embedded image
【0021】次いで、このナフトキノン単量体化合物を
100μM含むクロロホルム溶液を、電極面積1cm2
のグラッシーカーボン電極(固有抵抗約60×10-4Ω
/cm)上に0.05ml滴下し、約25℃で15分間
大気中で乾燥させた。この脂質膜上のナフトキノン単量
体化合物について25℃の窒素気流中でサイクリックボ
ルタンメトリーを測定した。測定は、参照電極にAg/
AgCl電極、対極には白金電極、作用極は前記グラッ
シーカーボン電極からなる3電極式セルを使用し、電位
幅が0.2Vから−0.8Vまで周期的に掃引した。そ
の結果、−0.46Vにフォーマル電位を有するナフト
キノン分子の可逆的な電極応答が見られたことから、本
ナフトキノン単量体化合物は、電子伝達機能を有するも
のであることを確認した。Next, a chloroform solution containing 100 μM of the naphthoquinone monomer compound was applied to an electrode area of 1 cm 2.
Glassy carbon electrode (specific resistance about 60 × 10 -4 Ω
/ Cm) and dried in air at about 25 ° C for 15 minutes. Cyclic voltammetry of the naphthoquinone monomer compound on the lipid membrane was measured in a nitrogen stream at 25 ° C. The measurement was performed using Ag /
An AgCl electrode, a platinum electrode as a counter electrode, and a three-electrode cell comprising the above-mentioned glassy carbon electrode as a working electrode were used, and the potential width was periodically swept from 0.2 V to -0.8 V. As a result, a reversible electrode response of a naphthoquinone molecule having a formal potential of −0.46 V was observed, confirming that the present naphthoquinone monomer compound has an electron transfer function.
【0022】[実施例2] 300mlの三口フラスコ
中に2,3−ジクロロ−1,4−ナフトキノン519.
3mg(2.29mmol)を入れ、クロロホルム20
mlに溶解させた。これにエタノール/水=10/1
(体積比)混合溶液33mlに溶解させた12−アミノ
ドデカン酸328mg(1.52mmol)を徐々に添
加した後、トリエチルアミンを滴下して60℃で90分
反応させた。反応液を濾過し、溶媒留去したものをクロ
ロホルム100mlに再度溶解させ、蒸留水で水洗を行
った。次いで、シリカゲルクロマトグラフィー(溶離
液:クロロホルム〜クロロホルム/メタノール=40/
1)により生成物を分離精製し、溶媒留去、真空乾燥さ
せ粉末状のアミノドデカン酸ナフトキノンを得た。これ
を100ml二口フラスコ中に入れ、クロロホルム20
mlに溶解させた。次いでN−ヒドロキシスクシンイミ
ド53.7mg(0.466mmol)を加え、0℃で
1時間撹拌した後、室温で11時間反応を行った。これ
にクロロホルム100mlを加えて濾過した後、蒸留水
で水洗し、有機相を溶媒留去した。得られたアミノウン
デカン酸ナフトキノンのスクシンイミド化合物にクロロ
ホルム20mlを加えて溶解した。これにジパルミトイ
ルホスファチジルエタノールアミン(DPPE)172
mg(0.249mmol)のクロロホルム溶液25m
lを加え、トリエチルアミンを滴下し、室温で20時間
反応させた。反応後、溶媒留去した後、シリカゲルカラ
ムクロマトグラフィー(溶離液:クロロホルム〜クロロ
ホルム/メタノール=40/1の混合液〜クロロホルム
/メタノール=20/1〜クロロホルム/メタノール=
9/1〜クロロホルム/メタノール=4/1)により分
離精製し、溶媒留去、真空乾燥させて最終生成物を得
た。Example 2 2,3-Dichloro-1,4-naphthoquinone in a 300 ml three-necked flask 519.
3 mg (2.29 mmol) were added, and chloroform 20 was added.
was dissolved in ml. Ethanol / water = 10/1
(Volume ratio) After gradually adding 328 mg (1.52 mmol) of 12-aminododecanoic acid dissolved in 33 ml of the mixed solution, triethylamine was added dropwise and reacted at 60 ° C for 90 minutes. The reaction solution was filtered, and the solvent was distilled off. The residue was dissolved again in 100 ml of chloroform and washed with distilled water. Subsequently, silica gel chromatography (eluent: chloroform-chloroform / methanol = 40 /
The product was separated and purified according to 1), the solvent was distilled off, and the residue was dried under vacuum to obtain powdery naphthoquinone aminododecanoate. This was put in a 100 ml two-necked flask, and chloroform 20 was added.
was dissolved in ml. Next, 53.7 mg (0.466 mmol) of N-hydroxysuccinimide was added, and the mixture was stirred at 0 ° C. for 1 hour and reacted at room temperature for 11 hours. After adding 100 ml of chloroform thereto and filtering, the mixture was washed with distilled water and the organic phase was evaporated. To the obtained succinimide compound of naphthoquinone aminoundecanoate was added 20 ml of chloroform and dissolved. This is followed by dipalmitoyl phosphatidylethanolamine (DPPE) 172
mg (0.249 mmol) of chloroform solution 25m
1 was added, triethylamine was added dropwise, and the mixture was reacted at room temperature for 20 hours. After the reaction, after distilling off the solvent, silica gel column chromatography (eluent: chloroform-chloroform / methanol = 40/1 mixture-chloroform / methanol = 20 / 1-chloroform / methanol =
9/1 to chloroform / methanol = 4/1), and the solvent was distilled off and dried under vacuum to obtain a final product.
【0023】最終生成物は前記実施例1と同様の分析法
で同定し、このうちUV/vis吸収スペクトルの分析
では、237nmと276nmに吸収が見られたことか
ら、該生成物は燐脂質に結合した式(6)で表されるナ
フトキノン単量体化合物:(C10H4O2)Cl(NH)
(CH2)11(DPPE)であることを確認した。(収
率約56.9%)The final product was identified by the same analytical method as in Example 1 above. Among them, the UV / vis absorption spectrum analysis showed absorption at 237 nm and 276 nm. Naphthoquinone monomer compound represented by the formula (6): (C 10 H 4 O 2 ) Cl (NH)
It was confirmed to be (CH 2 ) 11 (DPPE). (Yield about 56.9%)
【0024】[0024]
【化6】 Embedded image
【0025】次いで、このナフトキノン単量体化合物を
実施例1と同様の方法・条件で窒素気流中でのサイクリ
ックボルタンメトリーを測定した。その結果、−0.4
3Vにフォーマル電位を有するナフトキノン分子の可逆
的な電極応答が見られたことから、本ナフトキノン単量
体化合物は、電子伝達機能を有するものであることを確
認した。Next, cyclic voltammetry of this naphthoquinone monomer compound in a nitrogen stream was measured in the same manner and under the same conditions as in Example 1. As a result, -0.4
Since a reversible electrode response of a naphthoquinone molecule having a formal potential of 3 V was observed, it was confirmed that the present naphthoquinone monomer compound has an electron transfer function.
【0026】[実施例3] 300mlの三口フラスコ
中に2,3−ジクロロ−9,10−アントラキノン63
4.0mg(2.30mmol)を入れ、クロロホルム
20mlに溶解させた。これに、エタノール10体積部
に対し、水1体積部を混合した溶液33mlに溶解させ
た4−アミノペンタン酸178mg(1.51mmo
l)を徐々に添加した後、トリエチルアミンを滴下し、
65℃で90分反応させた。反応液を濾過し、溶媒留去
したものをクロロホルム100mlに再度溶解させ、蒸
留水で水洗を行った。次いで、シリカゲルクロマトグラ
フィー(溶離液:クロロホルム〜クロロホルム/メタノ
ール=40/1)により分離精製した生成物を溶媒留去
後、真空乾燥させ、粉末状のアミノペンタン酸アントラ
キノンを得た。これを100ml二口フラスコ中に11
1mg(0.310mmol)入れ、クロロホルム20
mlに溶解させた。次いで、N−ヒドロキシスクシンイ
ミド53.7mg(0.466mol)とN,N’−ジ
シクロヘキシルカルボジイミド(DCC)96.2mg
(0.466mmol)を加え、0℃で1時間撹拌した
後、室温で11時間反応を行った。これにクロロホルム
100mlを加えて濾過した後、蒸留水で水洗し、有機
相を溶媒留去した。得られたアミノペンタン酸アントラ
キノンのスクシンイミド化合物にクロロホルム20ml
を加えて溶解し、これにジパルミトイルホスファチジル
エタノールアミン(DPPE)174mg(0.250
mmol)のクロロホルム溶液25mlを加え、トリエ
チルアミンを数滴滴下し室温で20時間反応させた。反
応後、溶媒留去し、シリカゲルカラムトグラフィー(溶
離液:クロロホルム〜クロロホルム/メタノール=40
/1〜クロロホルム/メタノール=20/1〜クロロホ
ルム/メタノール=9/1〜クロロホルム/メタノール
=4/1)により分離精製し、溶媒留去、真空乾燥する
ことにより最終生成物を得た。Example 3 2,3-dichloro-9,10-anthraquinone 63 was placed in a 300 ml three-necked flask.
4.0 mg (2.30 mmol) was added and dissolved in 20 ml of chloroform. 178 mg of 4-aminopentanoic acid (1.51 mmol) dissolved in 33 ml of a solution obtained by mixing 1 part by volume of water with 10 parts by volume of ethanol.
l) was slowly added, and then triethylamine was added dropwise.
The reaction was performed at 65 ° C. for 90 minutes. The reaction solution was filtered, and the solvent was distilled off. The residue was dissolved again in 100 ml of chloroform and washed with distilled water. Next, the product separated and purified by silica gel chromatography (eluent: chloroform to chloroform / methanol = 40/1) was evaporated, and the residue was dried under vacuum to obtain powdery anthraquinone aminopentanoate. Put this in a 100 ml two-necked flask
1 mg (0.310 mmol), chloroform 20
was dissolved in ml. Next, 53.7 mg (0.466 mol) of N-hydroxysuccinimide and 96.2 mg of N, N′-dicyclohexylcarbodiimide (DCC).
(0.466 mmol), and the mixture was stirred at 0 ° C. for 1 hour, and then reacted at room temperature for 11 hours. After adding 100 ml of chloroform thereto and filtering, the mixture was washed with distilled water and the organic phase was evaporated. Chloroform 20 ml was added to the obtained succinimide compound of anthraquinone aminopentanoate.
Was added and dissolved, and 174 mg (0.250) of dipalmitoylphosphatidylethanolamine (DPPE) was added thereto.
(mmol) in 25 ml of a chloroform solution was added, and a few drops of triethylamine were added dropwise, followed by reaction at room temperature for 20 hours. After the reaction, the solvent was distilled off and silica gel column chromatography (eluent: chloroform-chloroform / methanol = 40)
/ 1-chloroform / methanol = 20/1-chloroform / methanol = 9/1-chloroform / methanol = 4/1), and the solvent was distilled off and dried under vacuum to obtain the final product.
【0027】最終生成物は前記実施例1と同様の分析法
で同定し、このうちUV/vis吸収スペクトルの分析
では、258nmと329nmに吸収が見られたことか
ら、該生成物は燐脂質に結合した式(7)で表されるア
ントラキノン単量体化合物:(C14H6O2)Cl(N
H)(CH2)4(DPPE)であることを確認した。
(収率約45.3%)The final product was identified by the same analysis method as in Example 1 above. Among them, the UV / vis absorption spectrum analysis showed absorption at 258 nm and 329 nm. An anthraquinone monomer compound represented by the formula (7): (C 14 H 6 O 2 ) Cl (N
H) (CH 2 ) 4 (DPPE).
(Yield about 45.3%)
【0028】[0028]
【化7】 Embedded image
【0029】次いで、このアントラキノン単量体化合物
を実施例1と同様の方法・条件で窒素気流中でのサイク
リックボルタンメトリーを測定した。その結果、−0.
49Vにフォーマル電位を有するアントラキノン分子の
可逆的な電極応答が見られたことから、本アントラキノ
ン単量体化合物は、電子伝達機能を有するものであるこ
とを確認した。Next, cyclic voltammetry of this anthraquinone monomer compound in a nitrogen stream was measured in the same manner and under the same conditions as in Example 1. As a result, -0.
Since a reversible electrode response of an anthraquinone molecule having a formal potential of 49 V was observed, it was confirmed that the present anthraquinone monomer compound has an electron transfer function.
【0030】[実施例4] 50mlの二口フラスコ中
に9,10−アントラキノン−2−カルボン酸100m
g(0.397mmol)を入れ、ベンゼン20mlに
懸濁させ30分還流させた。これに塩化チオニル8.7
ml(0.119mmol)を加え、9時間還流させ、
更にベンゼン50mlを加えて塩化チオニル臭が無くな
るまで溶媒留去を繰り返した。これに、エタノール10
体積部に対し、水1体積部を混合した溶液33mlに溶
解させた4−アミノペンタン酸177mg(1.50m
mol)を徐々に添加した後、トリエチルアミンを滴下
し、65℃で90分反応させた。反応液を濾過し、溶媒
留去したものをクロロホルム100mlに再度溶解さ
せ、蒸留水で水洗を行った。次いで、シリカゲルクロマ
トグラフィー(溶離液:クロロホルム〜クロロホルム/
メタノール=40/1)により分離精製した生成物を溶
媒留去後、真空乾燥させ、粉末状のカルバモイルペンタ
ン酸アントラキノンを得た。これを100ml二口フラ
スコ中に110mg(0.310mmol)入れ、クロ
ロホルム20mlに溶解させた。次いで、N−ヒドロキ
シスクシンイミド53.7mg(0.466mol)と
N,N’−ジシクロヘキシルカルボジイミド(DCC)
96.2mg(0.466mmol)を加え、0℃で1
時間撹拌した後、室温で11時間反応を行った。これに
クロロホルム100mlを加えて濾過した後、蒸留水で
水洗し、有機相を溶媒留去した。得られたアミノペンタ
ン酸アントラキノンのスクシンイミド化合物にクロロホ
ルム20mlを加えて溶解し、これにジパルミトイルホ
スファチジルエタノールアミン(DPPE)175mg
(0.250mmol)のクロロホルム溶液25mlを
加え、トリエチルアミンを数滴滴下し室温で20時間反
応させた。反応後、溶媒留去し、シリカゲルカラムトグ
ラフィー(溶離液:クロロホルム〜クロロホルム/メタ
ノール=40/1〜クロロホルム/メタノール=20/
1〜クロロホルム/メタノール=9/1〜クロロホルム
/メタノール=4/1)により分離精製し、溶媒留去、
真空乾燥することにより最終生成物を得た。Example 4 100 m of 9,10-anthraquinone-2-carboxylic acid was placed in a 50 ml two-necked flask.
g (0.397 mmol) was added, suspended in 20 ml of benzene, and refluxed for 30 minutes. 8.7 of thionyl chloride
ml (0.119 mmol), reflux for 9 hours,
Further, 50 ml of benzene was added, and the solvent distillation was repeated until the thionyl chloride odor disappeared. Add ethanol 10
177 mg of 4-aminopentanoic acid dissolved in 33 ml of a solution obtained by mixing 1 part by volume of water with respect to 1 part by volume (1.50 m
mol)), triethylamine was added dropwise, and the mixture was reacted at 65 ° C. for 90 minutes. The reaction solution was filtered, and the solvent was distilled off. The residue was dissolved again in 100 ml of chloroform and washed with distilled water. Then, silica gel chromatography (eluent: chloroform-chloroform /
The product separated and purified using methanol = 40/1) was evaporated, and the residue was dried under vacuum to obtain powdery anthraquinone carbamoylpentanoate. 110 mg (0.310 mmol) of this was placed in a 100 ml two-necked flask, and dissolved in 20 ml of chloroform. Then, 53.7 mg (0.466 mol) of N-hydroxysuccinimide and N, N′-dicyclohexylcarbodiimide (DCC)
96.2 mg (0.466 mmol) was added, and at 0 ° C., 1
After stirring for an hour, the reaction was performed at room temperature for 11 hours. After adding 100 ml of chloroform thereto and filtering, the mixture was washed with distilled water and the organic phase was evaporated. 20 ml of chloroform was added to the obtained succinimide compound of anthraquinone aminopentanoate and dissolved, and 175 mg of dipalmitoylphosphatidylethanolamine (DPPE) was added thereto.
(0.250 mmol) of a chloroform solution (25 ml) was added, and a few drops of triethylamine were added dropwise, followed by reaction at room temperature for 20 hours. After the reaction, the solvent was distilled off and silica gel column chromatography (eluent: chloroform to chloroform / methanol = 40/1 to chloroform / methanol = 20 /
1 / chloroform / methanol = 9/1 to chloroform / methanol = 4/1).
The final product was obtained by vacuum drying.
【0031】最終生成物は前記実施例1と同様の分析法
で同定し、このうちUV/vis吸収スペクトル分析で
は、258nmと329nmに吸収が見られたことか
ら、該生成物は燐脂質に結合した式(8)で表されるア
ントラキノン単量体化合物:(C14H6O2)H(CON
H)(CH2)4(DPPE)であることを確認した。
(収率約47.1%)The final product was identified by the same analysis method as in Example 1 above. Among them, UV / vis absorption spectrum analysis showed absorption at 258 nm and 329 nm. Anthraquinone monomer compound represented by formula (8): (C 14 H 6 O 2 ) H (CON
H) (CH 2 ) 4 (DPPE).
(Yield about 47.1%)
【0032】[0032]
【化8】 Embedded image
【0033】次いで、このアントラキノン単量体化合物
を実施例1と同様の方法・条件で窒素気流中でのサイク
リックボルタンメトリーを測定した。その結果、−0.
51Vにフォーマル電位を有するアントラキノン分子の
可逆的な電極応答が見られたことから、本アントラキノ
ン単量体化合物は、電子伝達機能を有するものであるこ
とを確認した。Next, cyclic voltammetry of this anthraquinone monomer compound in a nitrogen stream was measured in the same manner and under the same conditions as in Example 1. As a result, -0.
Since a reversible electrode response of an anthraquinone molecule having a formal potential of 51 V was observed, it was confirmed that the present anthraquinone monomer compound has an electron transfer function.
【0034】[0034]
【発明の効果】本発明の新規なキノン誘導体は、溶液系
のみならず気流中に於いても優れた電子伝達機能を有す
る単量体化合物であることから、特に乾燥脂質膜や金属
と結合してなるキノン誘導体などでは、大気中等の日常
環境下で用いることができるエネルギー変換部材として
十分適用できる可能性がある。The novel quinone derivative of the present invention is a monomer compound having an excellent electron transfer function not only in a solution system but also in an air stream. Such a quinone derivative may be sufficiently applicable as an energy conversion member that can be used in a daily environment such as the atmosphere.
Claims (2)
される基、R2は水素またはハロゲン原子、nは2〜2
0の整数を表す。]で示される基からなるナフトキノン
単量体化合物を特徴とするキノン誘導体。1. A compound of the general formula (1) [In the formula (1), R 1 is an imino group or a group represented by —CONH—, R 2 is a hydrogen or halogen atom, and n is 2 to 2
Represents an integer of 0. ] The quinone derivative characterized by the naphthoquinone monomer compound which consists of a group shown by these.
される基、R2は水素またはハロゲン原子、nは2〜2
0の整数を表す。]で示される基からなるアントラキノ
ン単量体化合物を特徴とするキノン誘導体。2. A compound of the general formula (2) [In the formula (2), R 1 is an imino group or a group represented by —CONH—, R 2 is a hydrogen or halogen atom, and n is 2 to 2.
Represents an integer of 0. ] The quinone derivative characterized by the anthraquinone monomer compound which consists of a group shown by these.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9096699A JPH10279549A (en) | 1997-03-31 | 1997-03-31 | Quinone derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9096699A JPH10279549A (en) | 1997-03-31 | 1997-03-31 | Quinone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH10279549A true JPH10279549A (en) | 1998-10-20 |
Family
ID=14172019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9096699A Pending JPH10279549A (en) | 1997-03-31 | 1997-03-31 | Quinone derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10279549A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006156354A (en) * | 2004-10-29 | 2006-06-15 | Sony Corp | Electron mediator, enzyme-immobilized electrode, fuel cell, electronic device, mobile object, power generation system, cogeneration system, and electrode reaction utilization device |
-
1997
- 1997-03-31 JP JP9096699A patent/JPH10279549A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006156354A (en) * | 2004-10-29 | 2006-06-15 | Sony Corp | Electron mediator, enzyme-immobilized electrode, fuel cell, electronic device, mobile object, power generation system, cogeneration system, and electrode reaction utilization device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0180492B1 (en) | Macropolycyclic complexes of rare earth metals and application as fluorescent labels | |
| Kraus et al. | Timed Diels-Alder reactions | |
| CN107245148B (en) | Three-dimensional porous supermolecule organic framework material and preparation method and application thereof | |
| US6673539B1 (en) | Fluorous tagging compounds and methods of use thereof | |
| JP4004976B2 (en) | Fullerene derivatives | |
| Sasabe et al. | Synthesis of [60] fullerene-functionalized rotaxanes | |
| JPH10279549A (en) | Quinone derivative | |
| WO2012089969A1 (en) | 3,6-functionalized 1,2,4,5-tetrazines, method for preparation, compositions comprising same and use in detecting organic pollutants | |
| EP2758391B1 (en) | Luminescent probes for biological marking and imagery, and preparation method thereof | |
| Tambute et al. | New chiral stationary phases containing a phosphorus atom as an asymmetric centre: I. Synthesis and first chromatographic results | |
| Ramalingam et al. | An improved synthesis of S-adenosylhomocysteine and related compounds | |
| Molina et al. | An efficient preparation of novel ferrocene derivatives via aza Wittig reaction and X-ray structure of bis (β-ferrocenylvinyl) carbodiimide | |
| JP3290623B2 (en) | Tubular compounds composed of calixarene | |
| JPH10279555A (en) | Dimerized quinone derivative compound | |
| CN117736171B (en) | Preparation method of AF488TSA | |
| JP4511125B2 (en) | Synthetic methods of phenylazomethine dendrimers and dendron derivatives | |
| JP4417032B2 (en) | photocatalyst | |
| CN112409415B (en) | Cyclometallated bisacetylene platinum (II) complex and its preparation method and application | |
| EP2766377A1 (en) | Luminescent probe for biological labelling and imaging, method for preparing same | |
| Klotz et al. | Synthesis of a tri‐tritiated heterobifunctional reagent, a potential tool in photoaffinity labeling technology | |
| JPH0262292B2 (en) | ||
| JP2003277373A (en) | Fullerene epoxide and method for producing the same | |
| CN109928978B (en) | 5,10,15,20-tetraaryl-3-thio-2-nitrogen-21-carbon chlorophyll compound and preparation method thereof | |
| Torosyan et al. | Synthesis of a conjugate of (R)-2, 2-dichloro-N-(1-phenylethyl) acetamide with fullerene C60 | |
| Tous et al. | Preparation and chromatographic use of 5′-fluorescent-labelled DNA probes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050125 |
|
| A977 | Report on retrieval |
Effective date: 20070914 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20070925 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071126 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20090421 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090504 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 3 Free format text: PAYMENT UNTIL: 20120522 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120522 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130522 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130522 Year of fee payment: 4 |